Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE- Apple, Fedex, Tesla, Dollar Tree, Five Below, Adobe

Wed, 18th Sep 2013 11:58

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s)

Sept 18 (Reuters) - Some U.S. stocks to watch on Wednesday:

FUTURES EDGE UP AHEAD OF FED DECISION

U.S. stock index futures edged higher on Wednesday ahead ofan announcement by the Federal Reserve on the future of itseconomic stimulus program.

** APPLE INC, Tuesday close $455.32, up 1 pctpremarket

The fingerprint reader on Apple's top-end iPhone 5S receivedan early thumbs up for ease of use from two influentialreviewers, helping dispel concerns about the scanning technologywhich has been notoriously unreliable in other cellphones.

** FEDEX CORP, Tuesday close $110.68, up 2.2 pctpremarket

Fedex posted a bigger quarterly profit as the couriercompany cut costs and its lower-priced ground shipping businessdid well.

** ADOBE SYSTEMS INC, Tuesday close $48.14, up 6pct premarket

The company, known for its Photoshop and Acrobat software,expects subscriber growth to top the 331,000 it added in thethird quarter due to strong demand from corporate customers.

** DOLLAR TREE INC, Tuesday close $55.83, up 3.5pct after market

The value retailer on Tuesday announced a $2 billion sharerepurchase program. The company also said it had entered intoagreements to repurchase $1 billion of its common shares under avariable maturity accelerated share repurchase program.

** FIVE BELOW INC, Tuesday close $48.5, down 2 pctafter market

The specialty value retailer on Tuesday announced asecondary offering by its shareholders. The company saidshareholders have agreed to sell 7.1 million shares of itscommon stock, of which 7 million shares would be sold by fundsaffiliated with Advent International and 100,000 shares will besold by Five Below's executive chairman.

** NATIONSTAR MORTGAGE HOLDINGS INC, Tuesday close$55.03

Jefferies raised its rating on the residential mortgageservicer's stock to "buy" from "hold", saying that highermortgage rates will lead to improved profitability and itexpects "another round of bulk servicing sales" in late 2013 orearly 2014. It also raised its target price on the stock to $64from $40.

** AON PLC, Tuesday close $70.01, up 2.2 pct aftermarket

Walgreen Co is moving 120,000 employees to the AonHewitt Corporate Health Exchange as part of a growing movementto offer employees cash to purchase their own plans on suchexchanges, the company will announce Wednesday.

** VANTIV INC, Tuesday close $27.25, up 1.1 pctafter market

Evercore raised its price target on the payment processor'sstock to $38 from $33 saying that it expects its net revenue infiscal year 2015 to grow by 12 percent due to higher revenue pertransaction.

** L&L ENERGY INC, Tuesday close $2.23

The U.S. coal miner with operations in China said it waslooking for acquisition opportunities in Northern China to addat least 1 million tons of coal production every year.

** AT&T INC, Tuesday close $34.75

AT&T is planning to announce on Wednesday that it willexpand its Latin American reach for business customers through acollaboration with Mexican billionaire Carlos Slim's AmericaMovil. AT&T will be able to do business in 15countries, including Argentina, Chile and Colombia, throughconnections with America Movil networks, according to arepresentative for AT&T.

** SMITHFIELD FOODS INC, Tuesday close $34.15

China's Shuanghui International is close to securingshareholder approval for its $4.7 billion offer for SmithfieldFoods, which would be the biggest purchase of a U.S. company bya Chinese firm, ahead of the vote next week, three peoplefamiliar with the matter said.

** GLAXOSMITHKLINE PLC , Tuesday close $51.13

A crackdown on corruption in China's pharmaceutical sectorhas hurt sales at international and local firms, with manydoctors at Chinese hospitals refusing to see drugrepresentatives for fear of being caught up in the wideningscandal. Britain's GlaxoSmithKline, the group at the centre ofthe furore, has suffered the most. Industry insiders expect itsChina drug sales growth to slow sharply or even reverse in thethird quarter after a 14 percent year-on-year rise in the threemonths to end-June.

** HONEYWELL INTERNATIONAL INC, Tuesday close $85.45

U.S. regulators on Tuesday ordered airlines to inspect morethan 3,800 planes to ensure that emergency locator beacons soldby Honeywell International do not have battery problems thatcould cause a fire.

** TESLA MOTORS INC, Tuesday close $166.23

Electric car company Tesla Motors is working to produce acar capable of running on "auto-pilot" within the next threeyears, CEO Elon Musk said, joining tech giant Google and rival carmakers in the race to roll a driverless car intothe market.

** PANDORA MEDIA INC, Tuesday close $25.19

The Internet radio company has won a Manhattan federal courtdecision rejecting efforts by some music publishers to narrow alicense that enables the largest U.S. Internet radio service toplay their music. (Compiled by Varun Aggarwal)

More News
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.